| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 823,215 | 872,188 | 1,005,005 | 1,126,122 | | Cost of Revenue | 389,178 | 1,411,839 | 1,153,900 | 1,234,959 | | | Gross Profit | 434,037 | (539,651) | (148,895) | (108,837) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 833,208 | 40,623 | 53,131 | 57,833 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (399,171) | (580,274) | (202,026) | (166,670) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,714 | 11,565 | 7,856 | 10,400 | | Earnings Before Interest And Taxes | (447,311) | (643,105) | (207,072) | (176,567) | | Interest Expense | 23,805 | 17,758 | 4,973 | 6,180 | | Income Before Tax | (471,116) | (660,863) | (212,045) | (182,747) | | Income Tax Expense | (65,603) | 3,043 | (10,425) | (13,635) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (405,513) | (663,906) | (201,620) | (169,112) | | | Non-recurring Events | | Discontinued Operations | 2,754 |
-
| 29,630 | 19,013 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (402,759) | (663,906) | (171,990) | (150,099) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($402,759) | ($663,906) | ($171,990) | ($150,099) |
|
0.45% Nasdaq 
0.20%
Income Statement
